(Q34677180)

3 August 2017

2 references

23 March 2019

25 October 2022

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening (English)

1 reference

RNA virus infectious disease

3 August 2017

1 reference

1 July 2020

3 references

23 March 2019

21 March 2019

1 July 2020

1 reference

cost-effectiveness analysis

1 July 2020

1 reference

1 reference

1

Susan J M Hahné

1 reference

3 August 2017

Irene K Veldhuijzen

2

1 reference

3 August 2017

Lucas Wiessing

3

1 reference

3 August 2017

Tek-Ang Lim

4

1 reference

3 August 2017

Mika Salminen

5

1 reference

3 August 2017

Marita van de Laar

6

1 reference

3 August 2017

language of work or name

1 reference

18 April 2013

5 references

3 August 2017

23 March 2019

21 March 2019

1 July 2020

25 October 2022

BMC Infectious Diseases

5 references

3 August 2017

23 March 2019

21 March 2019

1 July 2020

25 October 2022

13

1 reference

3 August 2017

page(s)

181

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

copyright license

4 references

23 March 2019

21 March 2019

1 July 2020

on focus list of Wikimedia project

25 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-13-181

0 references

cites work

Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Cost-effectiveness and population outcomes of general population screening for hepatitis C.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Models of community-based hepatitis B surface antigen screening programs in the U.S. and their estimated outcomes and costs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevention of HIV-1 infection with early antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The cost-effectiveness of screening for chronic hepatitis B infection in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Cost-effectiveness of targeted screening for hepatitis C in The Netherlands

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

WHO Guide for standardisation of economic evaluations of immunization programmes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Human herpesvirus 8 seroprevalence among internationally adopted children coming from Eastern Europe

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

A comparison of hepatitis B seroepidemiology in ten European countries.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

HIV and selected blood-borne and sexually transmitted infections in a predominantly Roma (Gypsy) neighbourhood in Budapest, Hungary: a rapid assessment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: the Camporeale model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Viral hepatitis in a multi-ethnic neighborhood in the Netherlands: results of a community-based study in a low prevalence country

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Cost-effectiveness of the national screening program for hepatitis C virus in the general population and the high-risk groups.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Communicable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The changing epidemiology of hepatitis C virus infection in Europe

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The costs and impacts of testing for hepatitis C virus antibody in public STD clinics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Self-reported hepatitis C virus antibody status and risk behavior in young injectors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis C virus infection in Scotland: epidemiological review and public health challenges

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Adherence to the screening program for HBV infection in pregnant women delivering in Greece

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Global epidemiology of hepatitis B virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Screening for Hepatitis C in injecting drug users: a cost utility analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis B and C markers among refugees in Athens

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The prevalence of hepatitis C in England and Wales.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Natural history of chronic hepatitis C

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Epidemiology of hepatitis C in Belgium: present and future

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis B prevalence and risk factors for HBsAg carriage amongst Somali households in Liverpool.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Community-based seroepidemiological survey of HCV infection in Catalonia, Spain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis C virus infection in the general population of northern Spain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

HCV infection in the general population of a Greek island: prevalence and risk factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Sexually transmitted diseases and sexual behavior in men attending an outpatients' clinic for gay men in Gothenburg, Sweden

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Impact of hepatitis C virus infection on healthy subjects on an Italian island

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Cost effectiveness of antenatal hepatitis B screening and vaccination of infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Hepatitis B Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Mathematical modelling of hepatitis C treatment for injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

The changing prevalence of hepatitis B virus infection among men who have sex with men who attended a sexually transmitted infections clinic in Edinburgh, Scotland between 1989 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Hepatitis C screening in genitourinary clinic attendees

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevention could be less cost-effective than cure: the case of hepatitis C screening policies in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Economic model of a birth cohort screening program for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Case finding for hepatitis C in primary care: a cost utility analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Efficiency of hepatitis C virus screening strategies in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

HCV screening to enable early treatment of hepatitis C: a mathematical model to analyse costs and outcomes in two populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Cost effectiveness of screening immigrants for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

The cost-effectiveness of alternative strategies against HBV in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Evaluation of a general practice based hepatitis C virus screening intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Development of a culturally tailored Internet intervention promoting hepatitis B screening in the Turkish community in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

High prevalence of HCV infection among the general population in a rural area of central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis C virus infection in different population groups in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

21 January 2018

HCV infection in Poland

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis C in Romania: different from European rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Italian blood donors with anti-HBc and occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis B virus infection among women at reproductive age at a German university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Seroepidemiology of hepatitis B virus infection in pregnant women in Catalonia (Spain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis C virus infection in a cohort of pregnant women in northern Greece and transmission of HCV from mother to child

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: a seroepidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

HCV prevalence in pregnant women in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Prevalence of hepatitis virus infections in Kosovar refugees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Immigration and hepatitis B virus: epidemiological, clinical and therapeutic aspects

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Vaccination induced immunity to the hepatitis B virus among high-risk groups in Glasgow 1993-2001: evaluating the effectiveness of the United Kingdom's selective immunisation policy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of hepatitis C in the general population in the Netherlands.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Mother to child transmission of hepatitis C virus in a province of northern Italy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Analysis of the shift of the transmission pattern for hepatitis C in a community in Central Italy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Universal hepatitis B screening of pregnant women in Denmark ascertains substantial additional infections: results from the first five months.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

The 2001 serological survey in the Czech Republic--viral hepatitis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716892

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

26 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-181

Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy

21 January 2018

1 reference

12 December 2020

Prevalence of markers of hepatitis B in the adult German population

1 reference

12 December 2020

Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region)

1 reference

12 December 2020

Surveillance of antenatal infections--HIV, hepatitis B, syphilis and rubella susceptibility in London

1 reference

12 December 2020

Prevalence of hepatitis C infection among general practice patients in the Lyon area, France

1 reference

12 December 2020

Horizontal transmission of HBV infection among students in Turkey

1 reference

12 December 2020

Antenatal hepatitis B screening - is there a need for a national policy?

1 reference

12 December 2020

Serological markers of selected sexually and blood transmitted infections in pregnant women and in newborns of HIV-positive mothers in the Slovak Republic

1 reference

12 December 2020

Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective

1 reference

12 December 2020

Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec

1 reference

12 December 2020

Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of Belgium

1 reference

12 December 2020

EMCDDA publishes guidelines on testing for HIV, viral hepatitis and other infections in injecting drug users

1 reference

12 December 2020

Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results

1 reference

12 December 2020

Prevalence of hepatitis B and C in the maternity department of a Greek district hospital

1 reference

12 December 2020

Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece

1 reference

12 December 2020

Hepatitis C in a sample of pregnant women in Switzerland: seroprevalence and socio-demographic factors

1 reference

12 December 2020

Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998

1 reference

12 December 2020

Payment for whole blood donations in Lithuania: the risk for infectious disease markers

1 reference

12 December 2020

Migrants and hepatitis B: new strategies for secondary prevention needed

1 reference

12 December 2020

Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-13-181

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference